White Paper

Clinical Development of CRISPR-Based Therapies in Oncology

Novel Therapies, Unique Challenges

Read more

Great strides have been made within pre-clinical research and discovery efforts that inform and enable an oncology development program based on CRISPR/Cas9 gene editing techniques, but there remains much to consider when it comes to implementing an early phase clinical trial.

Read our white paper – the second in a series to learn more.

Want to learn more about Worldwide Clinical Trials?